Syngene International Limited Bombay S.E.
Equities
SYNGENE
INE398R01022
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
699 INR | +0.68% | -1.24% | -0.31% |
Apr. 24 | Syngene International Limited Recommends Final Dividend for the Financial Year 2024 | CI |
Apr. 24 | Syngene International Limited Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.12% | 43.84B | |
+6.77% | 41.68B | |
+45.26% | 41.25B | |
-11.96% | 27.04B | |
+6.01% | 25.53B | |
-24.92% | 18.18B | |
-3.63% | 12.29B | |
+27.16% | 12.29B | |
+7.30% | 11.15B |
- Stock Market
- Equities
- SYNGENE Stock
- SYNGENE Stock
- News Syngene International Limited
- Syngene International : Logs 21% Drop in Consolidated Net Profit in Fiscal Q2; Shares Slide 3%